全球重组 C 因子检测市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

预计到 2032 年，全球重组 C 因子检测市场的市场规模将从 2023 年的 2,473 万美元达到近 5,620 万美元，2024-2032 年研究期间复合年增长率为 9.55%。

重组C因子测定用于测量内毒素暴露程度或热原水准。它使用重组蛋白和小萤光肽（螃蟹裂解物的合成替代品）进行检测。 rFC 具有三种不同的特异性：酶水平、光谱水平和基因水平，以便更好地将样品中存在的杂质与其他不相关物质和杂质区分开。内毒素检测在製药业中发挥着至关重要的作用，因为它可确保注射药品和医疗器材可供人类安全使用。这种测量技术的高灵敏度、特异性和较小的变异性可带来更精确和准确的读数。

市场动态

缓解鲎变形细胞裂解物 (LAL) 检测需求不断增长带来的压力的需求不断增长，以及 rfC 等替代内毒素检测测试的开发将成为该市场增长的趋势因素。这些检测方法的高精度、特异性、稳健性、可持续性、批次一致性、易用性和适当的灵敏度范围、增强的内毒素特异性和可重复性将扩大化妆品、研究、环境等多个产业的市场、食品和水质控制。鲎数量的减少及其灭绝的威胁将进一步推动该市场的成长。此市场发展的主要限制因素是与传统方法相比射频C缺乏功效。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球重组因子 C 检测市场的各个细分市场进行了包容性评估。重组 C 因子检测产业的成长和趋势为本研究提供了整体方法。

市场区隔

重组因子 C 检测市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按品牌

• PyroGene（PyroGene Bulk rFC（2,880 次测试）、PyroGene rFC（192 次测试））
• EndoNext（EndoZyme II、EndoZyme II GO、EndoLisa）

按最终用户

• 製药公司
• 生技公司
• 医疗器材公司
• 合约研究组织 (CRO)

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲重组 C 因子检测市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。重组 C 因子检测市场的主要参与者包括 Lonza Group、Hyglos GmbH - BioMeRieux Company。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：重组因子分析 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按品牌分類的市场吸引力分析
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球重整因子 C 检测市场分析：按品牌

• 按品牌概览
• 按品牌历史和预测数据分析
• PyroGene（PyroGene Bulk rFC（2,880 次测试）、PyroGene rFC（192 次测试））
• EndoNext（EndoZyme II、EndoZyme II GO、EndoLisa）

第 6 章：全球重组因子 C 检测市场分析：依最终用户分类

• 最终用户概述
• 最终用户的历史和预测数据分析
• 製药公司
• 生技公司
• 医疗器材公司
• 合约研究组织 (CRO)

第 7 章：全球重组因子分析市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 8 章：重组因子 C 侦测公司的竞争格局

• 重组C因子检测市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 9 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Lonza Group
• 公司概况
• 公司收入
• 产品
• 最新动态
• Hyglos GmbH - A BioMeRieux Company
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

The global demand for Recombinant Factor C Assay Market is presumed to reach the market size of nearly USD 56.2 Million by 2032 from USD 24.73 Million in 2023 with a CAGR of 9.55% under the study period 2024-2032.

Recombinant factor C assay is used to measure the scale of endotoxin exposure or level of pyrogens. It uses a recombinant protein and a small fluorescent peptide, a synthetic alternative to crab lysate, for detection. There are three different specificities of rFC, Enzymatic, Spectral, and Genetic level to better distinguish the impurity present in the sample from other, non-related substances and impurities. Endotoxin testing plays a critical role in the pharmaceutical industry since it ensures that injectable pharmaceutical products and medical devices are safe for human use. The high sensitivity, specificity, and lesser variability of this measurement technique lead to more precise and accurate readings.

MARKET DYNAMICS

The rising need to alleviate the pressures of a growing demand for the Limulus amoebocyte lysate (LAL) assay and the development of alternative endotoxin detection tests like rfC will be the trending factors for the growth of this market. The high accuracy, specificity, robustness, sustainability, lot-to-lot consistency, ease-of-use & a suitable sensitivity range, enhanced endotoxin specificity, and reproducibility of these assays will expand the market across several industries like cosmetics, research, environment, food, and water quality control. The decline in the horseshoe crab population and the threat of their extinction will further propel this market's growth. The main restraining factor for this market's development is the lack of efficacy of rfC compared to traditional methods.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Recombinant Factor C Assay. The growth and trends of Recombinant Factor C Assay industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Recombinant Factor C Assay market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Brand

• PyroGene (PyroGene Bulk rFC (2,880 tests), PyroGene rFC (192 tests))
• EndoNext (EndoZyme II, EndoZyme II GO, EndoLisa)

By End User

• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Companies
• Contract Research Organizations (CROs)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Recombinant Factor C Assay market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Recombinant Factor C Assay market include Lonza Group, Hyglos GmbH - A BioMeRieux Company. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. RECOMBINANT FACTOR C ASSAY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Brand
  • 3.7.2 Market Attractiveness Analysis By End User
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET ANALYSIS BY BRAND

• 5.1. Overview By Brand
• 5.2. Historical and Forecast Data Analysis By Brand
• 5.3. PyroGene (PyroGene Bulk rFC (2,880 tests), PyroGene rFC (192 tests)) Historic and Forecast Sales By Regions
• 5.4. EndoNext (EndoZyme II, EndoZyme II GO, EndoLisa) Historic and Forecast Sales By Regions

6. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET ANALYSIS BY END USER

• 6.1. Overview By End User
• 6.2. Historical and Forecast Data Analysis By End User
• 6.3. Pharmaceutical Companies Historic and Forecast Sales By Regions
• 6.4. Biotechnology Companies Historic and Forecast Sales By Regions
• 6.5. Medical Device Companies Historic and Forecast Sales By Regions
• 6.6. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions

7. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE RECOMBINANT FACTOR C ASSAY COMPANIES

• 8.1. Recombinant Factor C Assay Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF RECOMBINANT FACTOR C ASSAY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Lonza Group
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Hyglos GmbH - A BioMeRieux Company
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Brand (USD MN)
• PyroGene (PyroGene Bulk rFC (2,880 tests), PyroGene rFC (192 tests)) Market Sales By Geography (USD MN)
• EndoNext (EndoZyme II, EndoZyme II GO, EndoLisa) Market Sales By Geography (USD MN)
• Analysis By End User (USD MN)
• Pharmaceutical Companies Market Sales By Geography (USD MN)
• Biotechnology Companies Market Sales By Geography (USD MN)
• Medical Device Companies Market Sales By Geography (USD MN)
• Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
• Global Recombinant Factor C Assay Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Recombinant Factor C Assay Report
• Market Research Process
• Market Research Methodology
• Global Recombinant Factor C Assay Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Brand
• Market Attractiveness Analysis By End User
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Brand (USD MN)
• PyroGene (PyroGene Bulk rFC (2,880 tests), PyroGene rFC (192 tests)) Market Sales By Geography (USD MN)
• EndoNext (EndoZyme II, EndoZyme II GO, EndoLisa) Market Sales By Geography (USD MN)
• Global Market Analysis By End User (USD MN)
• Pharmaceutical Companies Market Sales By Geography (USD MN)
• Biotechnology Companies Market Sales By Geography (USD MN)
• Medical Device Companies Market Sales By Geography (USD MN)
• Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.